# A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.

> **NCT02080871** · NA · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 134 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Stenting of the Common and/or External Iliac Arteries

## Key facts

- **NCT ID:** NCT02080871
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-05
- **Final completion:** 2018-10
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080871, "A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02080871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*